Transmedics Group Inc (NASDAQ: TMDX) is 110.29% higher on its value in year-to-date trading and has touched a low of $36.42 and a high of $177.37 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $155.96 in the last trading session, with the day’s gains setting it 10.02%.
Currently trading at $165.98, the stock is 5.45% and 7.67% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing 6.42% at the moment leaves the stock 46.08% off its SMA200. TMDX registered 183.58% gain for a year compared to 6-month gain of 121.97%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.12% loss in the last 1 month and extending the period to 3 months gives it a 15.26%, and is 11.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.39% over the week and 4.90% over the month.
Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $5.54B and $358.76M in sales. Current P/E ratio is 4649.30 and Fwd P/E is 88.09. Profit margin for the company is 0.84%. Distance from 52-week low is 355.74% and -6.42% from its 52-week high. The company has generated returns on investments over the last 12 months (0.43%).
Transmedics Group Inc quarterly earnings per share for the current quarter are estimated at 0.3 with sales reaching $115.12M over the same period.The EPS is expected to grow by 264.00% this year, but quarterly earnings will post 84.00% year-over-year. Quarterly sales are estimated to grow 73.30% in year-over-year returns.
451.0 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 108.37% of the company’s shares. The shares outstanding are 32.67M, and float is at 32.23M with Short Float at 18.22%. Institutions hold 104.90% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.49 million shares valued at $676.31 million. The investor’s holdings represent 13.7063 of the TMDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $398.47 million to account for 8.0755 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.53 million shares representing 7.7118 and valued at over $380.53 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.5362 of the shares totaling 1.49 million with a market value of $223.83 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Hassanein Waleed H, the company’s President & CEO. SEC filings show that Hassanein Waleed H sold 8,625 shares of the company’s common stock on Sep 16 ’24 at a price of $153.42 per share for a total of $1.32 million. Following the sale, the insider now owns 61643.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on Sep 03 ’24 that Khayal Tamer I (Chief Commercial Officer) sold a total of 2,960 shares of the company’s common stock. The trade occurred on Sep 03 ’24 and was made at $159.60 per share for $0.47 million. Following the transaction, the insider now directly holds 20843.0 shares of the TMDX stock.
Still, SEC filings show that on Aug 27 ’24, Corcoran Nicholas disposed off 10,000 shares at an average price of $176.02 for $1.76 million. The insider now directly holds 21,105 shares of Transmedics Group Inc (TMDX).
